IOV-4001

· Iovance Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IOV-4001, covering 2024-12-05 to 2024-12-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer [Phase 1, Phase 2]

See pricing